GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials
RSS SUMMARY · AGGREGATED FROM TWSJ
Drug candidate bepirovirsen helped nearly a fifth of patients in two late-stage clinical trials achieve a functional cure, the company said.
Drug candidate bepirovirsen helped nearly a fifth of patients in two late-stage clinical trials achieve a functional cure, the company said.
Drug candidate bepirovirsen helped nearly a fifth of patients in two late-stage clinical trials achieve a functional cure, the company said.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
World News
Trump Tells Aides He Won’t Resume All-Out War With Iran Unless U.S. Troops Killed
TWSJ·1h ago·3 min read
Business
SoftBank CEO’s Bad Bets Left Him in Despair. An AI Spree Has Him Back on Top.
TWSJ·1h ago·3 min read
Business
Airlines Called Sustainable Fuel the Future. When an Energy Crisis Broke Out, Barely Any Was Around.
TWSJ·1d ago·3 min read
World News
Opinion | India Is Losing Its Economic Edge
TWSJ·4h ago·3 min read
Related
On this beat
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·6h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·9h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·10h ago·3 min read
Health
Diets high in ultraprocessed foods are associated with an increased risk of dementia, a new study says, adding to the list of health problems linked to foods such as cookies, hot dogs and pizza
TWSJ·16h ago·3 min read